LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Nintedanib | 1.11 | uM | LJP6 | 72 | hr | 1311 | 4771 | 5013 | 0.9518 | 0.9347 |
MDA-MB-231 | NU7441 | 1.11 | uM | LJP5 | 72 | hr | 1311 | 4461 | 5013 | 0.8898 | 0.8507 |
MDA-MB-231 | Dactolisib | 1.11 | uM | LJP5 | 72 | hr | 1311 | 2084 | 5013 | 0.4157 | 0.2086 |
MDA-MB-231 | NVP-TAE684 | 1.11 | uM | LJP6 | 72 | hr | 1311 | 2840 | 5013 | 0.5665 | 0.4129 |
MDA-MB-231 | Palbociclib | 1.11 | uM | LJP6 | 72 | hr | 1311 | 2692 | 5013 | 0.5370 | 0.3729 |
MDA-MB-231 | PD0325901 | 1.11 | uM | LJP5 | 72 | hr | 1311 | 1708 | 5013 | 0.3407 | 0.1071 |
MDA-MB-231 | PD0325901 | 1.11 | uM | LJP6 | 72 | hr | 1311 | 1604 | 5013 | 0.3199 | 0.0790 |
MDA-MB-231 | PD173074 | 1.11 | uM | LJP6 | 72 | hr | 1311 | 5190 | 5013 | 1.0352 | 1.0477 |
MDA-MB-231 | PD184352 | 1.11 | uM | LJP5 | 72 | hr | 1311 | 3403 | 5013 | 0.6788 | 0.5650 |
MDA-MB-231 | Pelitinib | 1.11 | uM | LJP5 | 72 | hr | 1311 | 4330 | 5013 | 0.8638 | 0.8155 |
MDA-MB-231 | PF431396 | 1.11 | uM | LJP5 | 72 | hr | 1311 | 1938 | 5013 | 0.3866 | 0.1692 |
MDA-MB-231 | PF477736 | 1.11 | uM | LJP5 | 72 | hr | 1311 | 3969 | 5013 | 0.7917 | 0.7178 |
MDA-MB-231 | PF562271 | 1.11 | uM | LJP6 | 72 | hr | 1311 | 3483 | 5013 | 0.6947 | 0.5866 |
MDA-MB-231 | PHA-665752 | 1.11 | uM | LJP5 | 72 | hr | 1311 | 4801 | 5013 | 0.9577 | 0.9427 |
MDA-MB-231 | PHA-793887 | 1.11 | uM | LJP6 | 72 | hr | 1311 | 1265 | 5013 | 0.2525 | -0.0124 |
MDA-MB-231 | PI103 | 1.11 | uM | LJP6 | 72 | hr | 1311 | 2447 | 5013 | 0.4882 | 0.3069 |
MDA-MB-231 | PLX-4720 | 1.11 | uM | LJP5 | 72 | hr | 1311 | 4897 | 5013 | 0.9768 | 0.9685 |
MDA-MB-231 | QL-X-138 | 1.11 | uM | LJP6 | 72 | hr | 1311 | 3975 | 5013 | 0.7929 | 0.7195 |
MDA-MB-231 | QL-XII-47 | 1.11 | uM | LJP6 | 72 | hr | 1311 | 2028 | 5013 | 0.4046 | 0.1936 |
MDA-MB-231 | Radicicol | 1.11 | uM | LJP5 | 72 | hr | 1311 | 1593 | 5013 | 0.3178 | 0.0761 |
MDA-MB-231 | Radicicol | 1.11 | uM | LJP6 | 72 | hr | 1311 | 1606 | 5013 | 0.3205 | 0.0797 |
MDA-MB-231 | Seliciclib | 1.11 | uM | LJP5 | 72 | hr | 1311 | 4676 | 5013 | 0.9327 | 0.9089 |
MDA-MB-231 | Ruxolitinib | 1.11 | uM | LJP5 | 72 | hr | 1311 | 5099 | 5013 | 1.0172 | 1.0233 |
MDA-MB-231 | XL147 | 1.11 | uM | LJP5 | 72 | hr | 1311 | 5004 | 5013 | 0.9981 | 0.9974 |
MDA-MB-231 | Saracatinib | 1.11 | uM | LJP6 | 72 | hr | 1311 | 2524 | 5013 | 0.5034 | 0.3275 |